These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

967 related items for PubMed ID: 11427792

  • 1. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
    Skowron F, Bérard F, Grézard P, Wolf F, Morel Y, Perrot H.
    Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
    [Abstract] [Full Text] [Related]

  • 2. The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients.
    Stuart KA, Busfield F, Jazwinska EC, Gibson P, Butterworth LA, Cooksley WG, Powell LW, Crawford DH.
    J Hepatol; 1998 Mar; 28(3):404-9. PubMed ID: 9551677
    [Abstract] [Full Text] [Related]

  • 3. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
    Dereure O, Aguilar-Martinez P, Bessis D, Perney P, Vallat C, Guillot B, Blanc F, Guilhou JJ.
    Br J Dermatol; 2001 Mar; 144(3):533-9. PubMed ID: 11260010
    [Abstract] [Full Text] [Related]

  • 4. Clinical relevance of hemochromatosis-related HFE C282Y/H63D gene mutations in patients on chronic dialysis.
    Canavese C, Bergamo D, Barbieri S, Timbaldi M, Thea A, Martina G, Damiani D, Fenoglio R, Donati-Marella B, Priolo G.
    Clin Nephrol; 2002 Dec; 58(6):438-44. PubMed ID: 12508966
    [Abstract] [Full Text] [Related]

  • 5. Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection.
    Martinelli AL, Zago MA, Roselino AM, Filho AB, Villanova MG, Secaf M, Tavella MH, Ramalho LN, Zucoloto S, Franco RF.
    Am J Gastroenterol; 2000 Dec; 95(12):3516-21. PubMed ID: 11151887
    [Abstract] [Full Text] [Related]

  • 6. Association of porphyria cutanea tarda with hereditary hemochromatosis.
    Mehrany K, Drage LA, Brandhagen DJ, Pittelkow MR.
    J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
    [Abstract] [Full Text] [Related]

  • 7. Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients.
    Vieira FM, Nakhle MC, Abrantes-Lemos CP, Cançado EL, Reis VM.
    An Bras Dermatol; 2013 Aug; 88(4):530-40. PubMed ID: 24068123
    [Abstract] [Full Text] [Related]

  • 8. Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT).
    Lamoril J, Andant C, Gouya L, Malonova E, Grandchamp B, Martásek P, Deybac JC, Puy H.
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):33-41. PubMed ID: 11929045
    [Abstract] [Full Text] [Related]

  • 9. C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients.
    Tannapfel A, Stölzel U, Köstler E, Melz S, Richter M, Keim V, Schuppan D, Wittekind C.
    Virchows Arch; 2001 Jul; 439(1):1-5. PubMed ID: 11499833
    [Abstract] [Full Text] [Related]

  • 10. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
    Toll A, Celis R, Ozalla MD, Bruguera M, Herrero C, Ercilla MG.
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
    [Abstract] [Full Text] [Related]

  • 11. Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda.
    Stölzel U, Köstler E, Schuppan D, Richter M, Wollina U, Doss MO, Wittekind C, Tannapfel A.
    Arch Dermatol; 2003 Mar; 139(3):309-13. PubMed ID: 12622622
    [Abstract] [Full Text] [Related]

  • 12. Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern France.
    Chiavérini C, Halimi G, Ouzan D, Halfon P, Ortonne JP, Lacour JP.
    Dermatology; 2003 Mar; 206(3):212-6. PubMed ID: 12673077
    [Abstract] [Full Text] [Related]

  • 13. [Are the hemochromatosis (HFE) gene mutation and hepatitis C virus (HCV) infection risk factors for porphyria cutanea tarda?].
    Nagy Z, Kószó F, Pár A, Nagy A, Horányi M, Morvay M, Dobozy A, Mózsik G.
    Orv Hetil; 2000 Sep 10; 141(37):2031-4. PubMed ID: 11037612
    [Abstract] [Full Text] [Related]

  • 14. Significance of H63D homozygosity in a Basque population with hemochromatosis.
    Castiella A, Zapata E, de Juan MD, Otazua P, Fernandez J, Zubiaurre L, Arriola JA, Gipuzkoa Hemochromatosis Group.
    J Gastroenterol Hepatol; 2010 Jul 10; 25(7):1295-8. PubMed ID: 20594259
    [Abstract] [Full Text] [Related]

  • 15. Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hungarian patients.
    Nagy Z, Kószó F, Pár A, Emri G, Horkay I, Horányi M, Karádi O, Rumi G, Morvay M, Varga V, Dobozy A, Mózsik G.
    Liver Int; 2004 Feb 10; 24(1):16-20. PubMed ID: 15101996
    [Abstract] [Full Text] [Related]

  • 16. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.
    Gottschalk R, Seidl C, Schilling S, Braner A, Seifried E, Hoelzer D, Kaltwasser JP.
    Eur J Immunogenet; 2000 Jun 10; 27(3):129-34. PubMed ID: 10940080
    [Abstract] [Full Text] [Related]

  • 17. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda.
    Bulaj ZJ, Phillips JD, Ajioka RS, Franklin MR, Griffen LM, Guinee DJ, Edwards CQ, Kushner JP.
    Blood; 2000 Mar 01; 95(5):1565-71. PubMed ID: 10688809
    [Abstract] [Full Text] [Related]

  • 18. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE, Hutzler S, Bollheimer LC, Buettner R, Hellerbrand C, Schöelmerich J, Palitzsch KD.
    Isr Med Assoc J; 2004 Jan 01; 6(1):30-3. PubMed ID: 14740507
    [Abstract] [Full Text] [Related]

  • 19. Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study.
    Cribier B, Chiaverini C, Dali-Youcef N, Schmitt M, Grima M, Hirth C, Lacour JP, Chosidow O.
    Dermatology; 2009 Jan 01; 218(1):15-21. PubMed ID: 19001803
    [Abstract] [Full Text] [Related]

  • 20. Human leukocyte antigen haplotypes and HFE mutations in Spanish hereditary hemochromatosis and sporadic porphyria cutanea tarda.
    Gonzalez-Hevilla M, de Salamanca RE, Morales P, Martínez-Laso J, Fontanellas A, Castro MJ, Rojo R, Moscoso J, Zamora J, Serrano-Vela JI, Arnaiz-Villena A.
    J Gastroenterol Hepatol; 2005 Mar 01; 20(3):456-62. PubMed ID: 15740492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.